Nagaraj Shetti of HDFC Securities noted that the market has reached an overhead resistance at around 23,300-23,400 levels, suggesting a potential minor dip in the short term, which could present a buying opportunity. He identified immediate support at the 22,900 level.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale